Status: Recruiting
Phase I Clinical Trial of YKYY031 for Injection in Patients With Advanced Solid Tumors
Phase I study of YKYY031 for injection in patients with advanced solid tumors
Participants needed: 76
Trial details
Phase: Phase 1Age: 18-75Biological sex: AllType: InterventionalSponsor: Beijing Youcare Kechuang Pharmaceutical Technology Co., Ltd.Updated: Aug 21, 2026Locations: 2
Eligibility criteria
Male or female patients aged 18 to 75 years old at the time of signing the infor... [+8]
Allergy to the investigational product (including any excipients). History of se... [+27]